Марина Совина (ночной редактор)
The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
。heLLoword翻译官方下载对此有专业解读
В России спрогнозировали стабильное изменение цен на топливо14:55。91视频对此有专业解读
一切从实际出发，务实是共产党人的必备品格。
Подростки распылили перцовый баллончик на пассажиров электрички под Петербургом20:54